Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study

Purpose Treatment with metamizole (dipyrone) has steadily increased in Germany over the last decade. The consequences of this increase for metamizole-induced agranulocytosis (MIA) are unclear. The present study addressed this topic using data from the Berlin Case–Control Surveillance Study.